• Achieve Life Sciences director Richard Alistair Stewart sold 20,626 common shares on Aug. 19, 2026 at $8.49.
• Direct holdings fell to 208,249 shares following the sale.
• Indirect holdings included 359 shares held by spouse, 882 shares held via Ricanto Limited.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-361182), on August 21, 2026, and is solely responsible for the information contained therein.